-transparent.png){kind=logo}
By addressing the issues of potency and metabolism in 3, a new series of LTD4 antagonists represented by (+)-26 was developed which is equipotent to clinical LTD4 antagonists Zafirlukast (1) and Pranlukast (2).
Related Publications
R J Chambers, and
G W Antognoli, and
J B Cheng, and
A Marfat, and
J S Pillar, and
J T Shirley, and
J W Watson
April 2000,
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
R J Chambers, and
G W Antognoli, and
J B Cheng, and
A Marfat, and
J S Pillar, and
J T Shirley, and
J W Watson
January 1990,
Methods in enzymology,
R J Chambers, and
G W Antognoli, and
J B Cheng, and
A Marfat, and
J S Pillar, and
J T Shirley, and
J W Watson
January 1989,
Advances in experimental medicine and biology,
R J Chambers, and
G W Antognoli, and
J B Cheng, and
A Marfat, and
J S Pillar, and
J T Shirley, and
J W Watson
November 1987,
Journal of medicinal chemistry,
R J Chambers, and
G W Antognoli, and
J B Cheng, and
A Marfat, and
J S Pillar, and
J T Shirley, and
J W Watson
April 1992,
Journal of medicinal chemistry,
R J Chambers, and
G W Antognoli, and
J B Cheng, and
A Marfat, and
J S Pillar, and
J T Shirley, and
J W Watson
January 1989,
Advances in prostaglandin, thromboxane, and leukotriene research,
R J Chambers, and
G W Antognoli, and
J B Cheng, and
A Marfat, and
J S Pillar, and
J T Shirley, and
J W Watson
July 1986,
Journal of medicinal chemistry,
R J Chambers, and
G W Antognoli, and
J B Cheng, and
A Marfat, and
J S Pillar, and
J T Shirley, and
J W Watson
April 1987,
The Journal of pharmacology and experimental therapeutics,
R J Chambers, and
G W Antognoli, and
J B Cheng, and
A Marfat, and
J S Pillar, and
J T Shirley, and
J W Watson
January 1988,
Drugs under experimental and clinical research,
R J Chambers, and
G W Antognoli, and
J B Cheng, and
A Marfat, and
J S Pillar, and
J T Shirley, and
J W Watson
May 1991,
Journal of medicinal chemistry,
